Insiders · CVKD

CVKD insider transactions

Cadrenal Therapeutics Inc. (CVKD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CVKD

• 122d
  Chief Financial Officer Szot Matthew K sold $69,233 worth of shares (9,933 units at $6.97), closing all direct ownership in the company (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 150d
  SEC Form 4 filed by Director Golden Lee Scott

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 150d
  New insider Golden Lee Scott claimed ownership of 1,667 shares (SEC Form 3)

  3 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 186d
  CEO and Chairman Pham Quang X sold $34,237 worth of shares (2,444 units at $14.01), decreasing direct ownership by 1% to 196,089 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 186d
  Chief Financial Officer Szot Matthew K sold $50,364 worth of shares (3,600 units at $13.99), decreasing direct ownership by 27% to 9,933 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 200d
  CEO and Chairman Pham Quang X sold $50,706 worth of shares (3,600 units at $14.09), decreasing direct ownership by 2% to 198,533 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 200d
  Chief Financial Officer Szot Matthew K sold $49,011 worth of shares (3,493 units at $14.03), decreasing direct ownership by 21% to 13,533 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 207d
  Chief Financial Officer Szot Matthew K sold $1,497 worth of shares (107 units at $13.99), decreasing direct ownership by 0.62% to 17,026 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 211d
  CEO and Chairman Pham Quang X sold $7,065 worth of shares (500 units at $14.13), decreasing direct ownership by 0.25% to 202,133 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 213d
  Chief Financial Officer Szot Matthew K sold $25,183 worth of shares (1,800 units at $13.99), decreasing direct ownership by 10% to 17,133 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 213d
  CEO and Chairman Pham Quang X sold $18,213 worth of shares (1,300 units at $14.01), decreasing direct ownership by 0.64% to 202,633 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 218d
  Chief Financial Officer Szot Matthew K sold $174,175 worth of shares (12,400 units at $14.05), decreasing direct ownership by 40% to 18,933 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 218d
  CEO and Chairman Pham Quang X sold $131,779 worth of shares (9,371 units at $14.06), decreasing direct ownership by 4% to 203,933 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 246d
  Chief Financial Officer Szot Matthew K sold $27,992 worth of shares (2,000 units at $14.00), decreasing direct ownership by 6% to 31,333 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 246d
  CEO and Chairman Pham Quang X sold $70,356 worth of shares (5,029 units at $13.99), decreasing direct ownership by 2% to 213,304 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 404d
  Amendment: SEC Form 4 filed by CEO and Chairman Pham Quang X

  4/A - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 450d
  SEC Form 4 filed by Chief Medical Officer Ferguson James J. Iii

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 450d
  SEC Form 3 filed by new insider Ferguson James J. Iii

  3 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Director Murphy John Raymond

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Director Wilson Glynn

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Director Zelenkofske Steven

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Chief Operating Officer Cole Jeffrey Scott

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Chief Financial Officer Szot Matthew K

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by CEO and Chairman Pham Quang X

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 463d
  SEC Form 4 filed by Director Lisicki Robert

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 752d
  Pham Quang X gifted 50,000 shares, decreasing direct ownership by 2% to 3,275,000 units (SEC Form 4)

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 759d
  SEC Form 4 filed by Cole Jeffrey Scott

  4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)
• 759d
  SEC Form 3 filed by new insider Cole Jeffrey Scott

  3 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)